Skip to main content
SpringerLink
Log in

Anxiolytic Drugs

  • Chapter
The Pharmacology of Sleep

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 116))

  • 135 Accesses

Abstract

Anxiety and the states of vigilance are closely interrelated. Thus, any anxious state, normal or pathologic, is associated with hyperarousal. Also, clinical experience shows that sleep disturbances are common among patients with diagnoseable anxiety disorders. For example, difficulties in falling and staying asleep are among the symptoms of generalized anxiety disorder (American Psychiatric Association 1994). Also, a considerable proportion of patients with panic disorder suffer from panic attacks during sleep and may secondarily develop a sleep disorder (Mellman and Uhde 1989). Further, insomnia and nightmares are among the main manifestations of post-traumatic stress disorder (American Psychiatric Association 1994). Finally, patients with obsessive compulsive disorder often present with sleep disturbances (Insel et al. 1982).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 429.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 549.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 549.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adam K, Oswald I (1989) Effects of repeated ritanserin on middle-aged poor sleepers. Psychopharmacology (Berl) 99:219–221

    Article  CAS  Google Scholar 

  • Allen S, Oswald I (1976) Anxiety and sleep after fosazepam. Br J Clin Pharmacol 3:165–168

    Article  PubMed  CAS  Google Scholar 

  • American Psychiatric Association (1994) Diagnostic statistical manual — IV (DSM-IV). Anceutan Psychiatric Association, Washington DC

    Google Scholar 

  • Ansseau M, Olie JP, von Frenckell R, Jourdain G, Stehle B, Guillet P (1991) Controlled comparison of the efficacy and safety of four doses of suriclone, diazepam and placebo in generalized anxiety disorder. Psychopharmacology (Berl) 104:439–443

    Article  CAS  Google Scholar 

  • Autret A, Minz M, Beillevaire T, Cathala HP, Schmitt H (1977) Effect of clonidine on sleep patterns in man. Eur J Clin Pharmacol 12:319–322

    Article  PubMed  CAS  Google Scholar 

  • Bender W, Greil W, Ruther E, Schnelle K (1979) Effects of the β-adrenoceptor blocking agent Sotalol on CNS: sleep, EEG, and psychophysiological parameters. J Clin Pharmacol 19:505–512

    PubMed  CAS  Google Scholar 

  • Benson KL, Csernansky JG, Zarcone VP (1991) The effect of ritanserin on slow wave sleep deficits and sleep continuity in schizophrenia. Sleep Res 20:170

    Google Scholar 

  • Betts TA, Alford C (1985) β-blockers and sleep: a controlled trial. Eur J Clin Pharmacol 28(suppl):65–68

    Article  PubMed  Google Scholar 

  • Bianchetti G, Dubruc C, Ascalone V, Thénot JPG (1993) Pharmacokinetic profile of alpidem: effect of age and pathological conditions. In: Bartholini G, Garreau M, Morselli PL, Zivkovic B (eds) Imidazopyridines in anxiety disorders: a novel experimental and therapeutic approach. Raven, New York, pp 121–131

    Google Scholar 

  • Birmanns B, Clarenback P (1989) Effects of serotonin-receptor antagonists on sleep and sleep related release of HGH, prolactin and Cortisol. In: Wauquier A, Dugovic C, Radulovacki M (eds) Slow wave sleep: physiological, pathophysiological and functional aspects. Raven, New York, pp 235–242

    Google Scholar 

  • Bliwise D, Seidel W, Greenblatt DJ, Dement W (1984) Nighttime and daytime efficacy of flurazepam and oxazepam in chronic insomnia. Am J Psychiatry 141:191–195

    PubMed  CAS  Google Scholar 

  • Bonnet M, Kramer M, Rosa R (1980) The hypnotic effectiveness of ketazolam in anxious subjects. Curr Ther Res 28:284–293.

    Google Scholar 

  • Bonnet M, Kramer M, Roth T (1981) A dose response study of the hypnotic effectiveness of alprazolam and diazepam in normal subjects. Psychopharmacology (Berl) 75:258–261

    Article  CAS  Google Scholar 

  • Boudoulas H, Schmidt H, Geleris P, Clark PW, Lewis RP (1983) Case reports on deterioration of sleep apnea during therapy with propranolol. Preliminary studies. Res Commun Chem Pathol Pharmacol 39:3–10

    PubMed  CAS  Google Scholar 

  • Charney DS, Heninger GR (1986) Abnormal regulation of noradrenergic function in panic disorders. Arch Gen Psychiatry 43:1042–1054

    Article  PubMed  CAS  Google Scholar 

  • Charney DS, Heninger GR, Hafstad KM, Capelli S, Redmond E (1983) Neurobiological mechanisms in human anxiety: recent clinical studies. Psychopharmacol Bull 19:470–475

    Google Scholar 

  • Da Roza Davis JM, Sharpley AL, Cowen PJ (1992a) Slow wave sleep and 5-HT2 receptor sensitivity in generalized anxiety disorder: a pilot study with ritanserin. Psychopharmacology (Berl) 108:387–389

    Article  Google Scholar 

  • Da Roza Davis JM, Sharpley AL, Solomon RA, Cowen PJ (1992b) Sleep and 5-HT2 receptor sensitivity in recovered depressed patients. J Affect Disord 24:177–182

    Article  Google Scholar 

  • Dahlitz M, Wells, James R, Idzikowski C, Parkes JD (1990) Treatment of insomnia with ritanserin. Lancet 336:379

    Article  PubMed  CAS  Google Scholar 

  • Dahlöf C, Dimenas E (1990) Side effects of β-blocker treatments as related to the central nervous system. Am J Med Sci 299:236–244

    Article  PubMed  Google Scholar 

  • Danjou P, Court LA, Feuerstein C, Vandel B, Rosenzweig P (1993) Anxiolytics and electrogenesis: alpidem effects on waking EEG and sleep architecture. In: Bartholini G, Garreau M, Morselli PL, Zivkovic B (eds) Imidazopyridines in anxiety disorders: a novel experimental and therapeutic approach. Raven, New York, pp 133–142

    Google Scholar 

  • Davidson J (1992) Drug therapy of post-traumatic stress disorder. Br J Psychiatry 160:309–314

    Article  PubMed  CAS  Google Scholar 

  • De Roeck J, Cluydts R, Schotte C, Rouckhout D, Cosyns P (1989) Explorative single-blind study on the sedative and hypnotic effects of buspirone in anxiety patients. Acta Psychiatr Scand 79:129–135

    Article  PubMed  Google Scholar 

  • Declerck AC, Wauquier A, Van der Ham-Veltman PHM, Celders Y (1987) Increase in slow-wave sleep in humans with the serotonin-S2 antagonist ritanserin. Curr Ther Res 41:427–432

    Google Scholar 

  • Dufour H, Wade A, Legris P, L’Héritier C, Priore P, Garreau M (1993) Efficacy of alpidem in anxiety disorders. In: Bartholini G, Garreau M, Morselli PL, Zivkovic B (eds) Imidazopyridines in anxiety disorders: a novel experimental and therapeutic approach. Raven, New York, pp 165–173

    Google Scholar 

  • Dunleavy DLF, McLean AW, Owald I (1971) Desibroquine, guanethidine, propranolol and human sleep. Psychopharmacology (Berl) 21:101–110

    Article  CAS  Google Scholar 

  • Ehrenstein W, Schaffler K, Müller-Limmroth W (1972) Die Wirkung von Oxazepam auf den gestörten Tagschlaf nach Nachtschichtarbeit. Arzneimittel forschung 22: 421–427

    PubMed  CAS  Google Scholar 

  • Eison MS, Temple DL (1986) Buspirone: review of its pharmacology and current perspectives on its mechanism of action. Am J Med 80 [Suppl 3B]: l-9

    Article  Google Scholar 

  • Gaillard JM, Kafi S (1979) Involvement of pre and postsynaptic receptors in catecholaminergic control of paradoxical sleep in man. Eur J Clin Pharmacol 15:83–89

    Article  PubMed  CAS  Google Scholar 

  • Gaillard JM, Iorio G, Kafi S, Blois R (1983) Paradoxical sleep rebound without previous debt: the effect of minute doses of clonidine in man. Sleep 6:60–66

    PubMed  CAS  Google Scholar 

  • Gammans RE, Mayol RF, Labudde JA (1986) Metabolism and disposition of buspirone. Am J Med 80(suppl 3b):41–51

    Article  PubMed  CAS  Google Scholar 

  • Gershon S, Eison AS (1983) Anxiolytic profiles. J Clin Psychiatry 44:45–56

    PubMed  CAS  Google Scholar 

  • Hamon M (1994) Neuropharmacology of anxiety: perspectives and prospects. TIPS 15:36–39

    PubMed  CAS  Google Scholar 

  • Hartmann E (1968) The effect of four drugs on sleep pattern in man. Psychopharmacologia (Berl) 12:346–353

    Article  CAS  Google Scholar 

  • Hartmann E, Cravens J (1973) The effects of long-term administration of psychotropic drugs on human sleep: VI. The effects of chlordiazepoxide. Psychopharmacologia (Berl) 33:233–245

    Article  CAS  Google Scholar 

  • Hubain PP, Castro P, Mesters P, De Maertelaer V, Mendlewicz J (1990) Alprazolam and amitriptyline in the treatment of major depressive disorder: a double-blind clinical and sleep EEG study. J Affect Disord 18:67–73

    Article  PubMed  CAS  Google Scholar 

  • Idzikowski C, Mills FJ, Glennard R (1986) 5-Hydroxytryptamine-2 antagonist increases human slow wave sleep. Brain Res 378:164–168

    Article  PubMed  CAS  Google Scholar 

  • Idzikowski C, Cowen PJ, Nutt D, Mills FJ (1987) The effects of chronic ritanserin treatment on sleep and the neuroendocrine response to L-tryptophan. Psychopharmacology (Berl) 93:416–420

    Article  CAS  Google Scholar 

  • Idzikowski C, Mills FJ, James RJ (1991) A dose-response study examining the effects of ritanserin on human slow wave sleep. Br J Clin Pharmacol 31:193–196

    Article  PubMed  CAS  Google Scholar 

  • Insel TR, Gillin JC, Moore A, Mendelson WB, Loewenstein RJ, Murphy DL (1982) The sleep of patients with obsessive-compulsive disorder. Arch Gen Psychiatry 39:1372–1377

    Article  PubMed  CAS  Google Scholar 

  • Issa FG (1992) Effect of clonidine in obstructive sleep apnea. Am Rev Respir Dis 145:435–439

    PubMed  CAS  Google Scholar 

  • Jimerson DC, Post RM, Stoddard FJ, Gillin JC, Bunney WE (1980) Preliminary trial of the noradrenergic agonist clonidine in psychiatric patients. Biol Psychiatry 15:45–57

    PubMed  CAS  Google Scholar 

  • Kahn RS, Moore C (1993) Serotonin in the pathogenesis of anxiety. In: Hoehn-Saric R, McLeod DR (eds) Biology of anxiety disorders. American Psychiatric Press, Washington, pp 61–102

    Google Scholar 

  • Kales A, Kales JD (1984) Evaluation and treatment of insomnia. Oxford University Press, New York

    Google Scholar 

  • Kales A, Soldatos CR, Cadieux RJ, Bixler EO, Tan T-L, Scharf MB (1979) Propranolol in the treatment of narcolepsy. Ann Intern Med 91:742–743

    Google Scholar 

  • Kales A, Soldatos CR, Caldwell AB, Charney DS, Kales JD, Markel D, Cadieux R (1980) Nightmares: clinical characteristics and personality patterns. Am J Psychiatry 137:1197–1201

    PubMed  CAS  Google Scholar 

  • Kales A, Bixler EO, Cadieux RJ, Schneck DW, Shaw LC III, Locke TW, Vela-Bueno A, Soldatos CR (1984) Sleep apnoea in a hypertensive population. Lancet 2:1005–1008

    Article  PubMed  CAS  Google Scholar 

  • Kales A, Bixler EO, Soldatos CR, Jacoby JA, Kales JD (1986) Lorazepam: effects on sleep and withdrawal phenomena. Pharmacology 32:121–130

    Article  PubMed  CAS  Google Scholar 

  • Kales A, Bixler EO, Vela-Bueno A, Soldatos CR, Manfredi RL (1987) Alprazolam: effects on sleep and withdrawal phenomena. J Clin Pharmacol 27:508–515

    PubMed  CAS  Google Scholar 

  • Kales A, Bixler EO, Vela-Bueno A, Cadieux RJ, Manfredi RL, Bitzer S, Kantner T (1988a) Effects of nadolol on blood pressure, sleep efficiency and sleep stages. Clin Pharmacol Ther 43:655–662

    Article  Google Scholar 

  • Kales A, Soldatos CR, Bixler EO, Kales JD, Vela-Bueno A (1988b) Diazepam: effects on sleep and withdrawal phenomena. J Clin Psychopharmacol 8:340–345

    Article  Google Scholar 

  • Kales A, Manfredi RL, Vgontzas AN, Baldassano CF, Kostakos K, Kales JD (1991) Clonazepam: sleep laboratory study of efficacy and withdrawal. J Clin Psychopharmacol 11:189–193

    Article  PubMed  CAS  Google Scholar 

  • Kales A, Vgontzas AN, Bixler EO (1994) Not all benzodiazepines are alike: update 1993. Proceedings of the 9th Congress of Psychiatry, Rio de Janeiro, 1993

    Google Scholar 

  • Kales JD, Kales A, Soldatos CR, Caldwell AB, Charney DS, Martin ED (1980) Night terrors: clinical characteristics and personality patterns. Arch Gen Psychiatry 37:1413–1417

    Article  PubMed  CAS  Google Scholar 

  • Kanno O, Clarenbach P (1985) Effect of clonidine and yohimbine on sleep in man: poly graphic study and EEG analysis by normalized slope descriptors. Electroencephalogr Clin Neurophysiol 60:478–484

    Article  PubMed  CAS  Google Scholar 

  • Kantola I, Rauhala E, Erkinjunti M, Mansury L (1991) Sleep disturbances in hypertension: a double-blind study between isradipine and metoprolol. J Cardiovasc Pharmacol 18 [Suppl 3]:S41-S45

    PubMed  Google Scholar 

  • Karacan I, O’Brien GS, Williams RL, Salis PJ, Thornby JI (1973) Methodology for electroencephalographic sleep evaluation of drugs. In: Koella WP, Levin P (eds) Sleep: physiology, biochemistry, psychology, pharmacology, clinical implications. Karger, Basel, pp 463–476

    Google Scholar 

  • Kayed K, Godtlibsen OB (1977) Effects of the β-adrenoceptor antagonists acebutolol and metoprolol on sleep pattern in normal subjects. Eur J Clin Pharmacol 12:323–326

    Article  PubMed  CAS  Google Scholar 

  • Koella WP (1985) CNS-related (side) effects of β-blockers with special reference to mechanisms of action. Eur J Clin Pharmacol 28 Suppl:55–63

    Google Scholar 

  • Kostis JB, Rosen RC (1987) Central nervous system effects of β-adrenergic-blocking drugs: the role of ancillary properties. Circulation 75:204–212

    Article  PubMed  CAS  Google Scholar 

  • Kostis JB, Rosen RC, Holzer BC, Randolph C, Taska L, Miller MH (1990) CNS side effects of centrally-active antihypertensive agents: a prospective, placebo-controlled study of sleep, mood state, and cognitive and sexual function in hypertensive males. Psychopharmacology (Berl) 102:163–170

    Article  CAS  Google Scholar 

  • Kramer M (1982) Dose-response effects of alprazolam on sleep architecture in normal subjects. Curr Ther Res 31:960–968

    CAS  Google Scholar 

  • Kramer M, Schoen L (1986) Short-term effects of adinazolam on sleep and postsleep behavior. Curr Ther Res 40:924–932

    CAS  Google Scholar 

  • Kramer M, Schoen LW, Scharf M (1984) Effects of alprazolam on sleep and performance in geriatric insomniacs. Curr Ther Res 35:67–76

    Google Scholar 

  • Lader M (1988) β-adrenoceptor antagonists in neuropsychiatry: an update. J Clin Psychiatry 49:213–223

    PubMed  CAS  Google Scholar 

  • Lammers GJ, Arends J, Declerck AC, Kamphuisen H AC, Schouwink G, Troost J (1991) Ritanserin, a 5-HT2 receptor blocker, as add-on treatment in narcolepsy. Sleep 14:130–132

    PubMed  CAS  Google Scholar 

  • Maling TJB, Dollery CT, Hamilton CA (1979) Clonidine and sympathetic activity during sleep. Clin Sci 57:509–514

    PubMed  CAS  Google Scholar 

  • Manfredi RL, Kales A, Vgontzas AN, Bixler EO, Isaac MA, Falcone CM (1991) Buspirone: sedative or stimulant effect? Am J Psychiatry 148:1213–1217

    PubMed  CAS  Google Scholar 

  • McAinsh J, Cruickshank JM (1990) Beta-blockers and central nervous system side effects. Pharmacol Ther 46:163–197

    Article  PubMed  CAS  Google Scholar 

  • McClure DJ, Walsh J, Chang H, Olah A, Wilson R, Pecknold JC (1988) Comparison of lorazepam and flurazepam as hypnotic agents in chronic insomniacs. J Clin Pharmacol 28:52–63

    PubMed  CAS  Google Scholar 

  • Meier-Ewert K, Matsubayashi K, Benter L (1985) Propranolol: long-term treatment in narcolepsy-cataplexy. Sleep 8:95–104

    PubMed  CAS  Google Scholar 

  • Mellman TA, Uhde TW (1989) Electroencephalographic sleep in panic disorder. Arch Gen Psychiatry 46:178–184

    Article  PubMed  CAS  Google Scholar 

  • Mendelson WB, Maczaj M, Holt J (1991) Effects of buspirone on sleep-related respiration in obstructive sleep apnea. Sleep Res 20:69

    Google Scholar 

  • Mitler MM, Browman CP, Menn SJ, Gujavarty K, Timms RM (1986) Nocturnal myoclonus: treatment efficacy of clonazepam and temazepam. Sleep 9:385–392

    PubMed  CAS  Google Scholar 

  • Monti JM, Alterwain P, Estevez F, Alvarifio F, Giusti M, Olivera S, Labraga P (1993) The effects of ritanserin on mood and sleep in abstinent alcoholic patients. Sleep 16:647–654

    PubMed  CAS  Google Scholar 

  • Moore S, Bonnet M, Kramer M, Roth T (1981) A dose-response study of the hypnotic effectiveness of ketazolam in normal subjects. Curr Ther Res 29:704–713

    CAS  Google Scholar 

  • Nicholson AN, Pascoe PA (1991) Presynaptic alpha2-adrenoceptor function and sleep in man: studies with clonidine and idazoxan. Neuropharmacology 30:367–372

    Article  PubMed  CAS  Google Scholar 

  • Nicholson AN, Stone BM (1979) Diazepam and 3-hydroxydiazepam (temazepam) and sleep of middle age. Br J Clin Pharmacol 7:463–468

    Article  PubMed  CAS  Google Scholar 

  • Nicholson AN, Stone BM, Clarke CH, Ferres HM (1976a) Effect of N-desmethyl-diazepam (nordiazepam) and a precursor, potassium clorazepate on sleep in man. Br J Clin Pharmacol 3:429–438

    Article  Google Scholar 

  • Nicholson AN, Stone BM, Clarke CH (1976b) The effect of diazepam and fosazepam (a soluble derivative of diazepam) on sleep in man. Br J Clin Pharmacol 3:533–541

    Article  Google Scholar 

  • Norman TR, Burrows GD (1986) Anxiety and the benzodiazepine receptor. Prog Brain Res 65:73–90

    Article  PubMed  CAS  Google Scholar 

  • Noyes R (1982) Beta-blocking drugs and anxiety. Psychosomatics 23:155–170

    PubMed  Google Scholar 

  • Oakley NR, Tyers MB (1992) 5-HT receptor types and anxiety. In: Mendlewicz J, Racagni G (eds) Target receptors for anxiolytics and hypnostics: from molecular pharmacology to therapeutics. Karger, Basel, pp 11–23 (International academy of biomedicine and drug research, vol 3)

    Google Scholar 

  • Paiva T, Arriaga F, Wauquier A, Lara E, Largo R, Leitao JN (1988) Effects of ritanserin on sleep disturbances of dysthymic patients. Psychopharmacology (Berl) 96:395–399

    Article  CAS  Google Scholar 

  • Pancheri P, Bressa GM, Borghi C (1993) Double-bind randomized studies on the therapeutic action of alpidem in generalized anxiety disorders. In: Bartholini G, Garreau M, Morselli PL, Zivkovic B (eds) Imidazopyridines in anxiety disorders: a novel experimental and therapeutic approach. Raven, New York, pp 155–164

    Google Scholar 

  • Reid JL (1981) The clinical pharmacology of clonidine and related central antihypertensive agents. Br J Clin Pharmacol 12:295–302

    Article  PubMed  CAS  Google Scholar 

  • Risberg AM, Henricsson S, Ingvar DH (1977) Evaluation of the effect of fosazepam (a new benzodiazepine), nitrazepam and placebo on sleep patterns of normal subjects. Eur J Clin Pharmacol 12:105–109

    Article  PubMed  CAS  Google Scholar 

  • Ruiz-Primo E, Haro R, Valencia M (1989) Polysomnographie effects of ritanserin in insomniacs: a crossed double-blind controlled study. Sleep Res 18:72

    Google Scholar 

  • Saletu B, Schultes M, Grünberger J, Chaudry HR (1986) Sleep laboratory study of a new antianxiety drug, alpidem: short-term trial. Curr Ther Res 40:769–779

    Google Scholar 

  • Saletu B, Frey R, Grünberger J, Krupka M, Anderer P, Musch B (1990) Sleep laboratory studies on single dose effects of suriclone. Br J Clin Pharmacol 30:703–710

    Article  PubMed  CAS  Google Scholar 

  • Scharf MB, Kales A, Bixler EO, Jacoby JA, Schweitzer PK (1982) Lorazepam efficacy, side effects and rebound phenomena. Clin Pharmacol Ther 31:175–179

    Article  PubMed  CAS  Google Scholar 

  • Scharf MB, Denson DD, Thompson GA, Goff PJ (1985) Carryover hypnotic effectiveness of diazepam. Curr Ther Res 37:309–317

    Google Scholar 

  • Scharf MB, Brannen DE, Berkowitz DV, McDannold M (1993) Comparative effects of buspirone and alprazolam on snoring and sleep apnea in geriatric patients. Sleep Res 22:47

    Google Scholar 

  • Seidel WF, Cohen SA, Bliwise NG, Dement WC (1985a) Buspirone: an anxiolytic without sedative effects. Psychopharmacology (Berl) 87:371–373

    Article  Google Scholar 

  • Seidel WF, Cohen SA, Wilson L, Dement WC (1985b) Effects of alprazolam and diazepam on the daytime sleepiness of nonanxious subjects. Psychopharmacology (Berl) 87:194–197

    Article  Google Scholar 

  • Sharpley AL, Solomon RA, Fernando AI, Da Roza Davis JM, Cowen PJ (1990) Dose-related effects of selective 5-HT2 receptor antagonists on slow wave sleep in humans. Psychopharmacology (Berl) 101:568–569

    Article  CAS  Google Scholar 

  • Spiegel R, Devos JE (1980) Central effects of guanfacine and clonidine during wakefulness and sleep in healthy subjects. Br J Clin Pharmacol 10:165S–168S

    Article  PubMed  Google Scholar 

  • Staner L, Kempenaers C, Simonnet MP, Fransolet L, Mendlewicz J (1992) 5-HT2 receptor antagonism and slow-wave sleep in major depression. Acta Psychiatr Scand 86:133–137

    Article  PubMed  CAS  Google Scholar 

  • Uhde TW, Stein MB, Vittone BJ, Siever LJ, Boulenger JF, Klein E, Mellman TA (1989) Behavioral and physiologic affects of short-term and long-term administration of clonidine in panic disorder. Arch Gen Psychiatry 46:170–177

    Article  PubMed  CAS  Google Scholar 

  • Van Peer A, Gasparini R, Woestenborghs R, Heykants J, Gelders Y (1985) Intravenous pharmacokinetics and effect of food on the bioavailability of ritanserin in healthy volunteers. Naunyn Schmiedebergs Arch Pharmacol [Suppl 330]:R15

    Google Scholar 

  • Vogel G, Minter K, Clifton T (1987) The effect of adinazolam on sleep variables in patients with melancholia. Sleep Res 16:155

    Google Scholar 

  • Walsh JK, Schweitzer PK, Parwatikar P (1983) Effects of lorazepam and its withdrawal on sleep, performance and subjective state. Clin Pharmacol Ther 34: 496–500

    Article  PubMed  CAS  Google Scholar 

  • Weichler U, Herres-Mayer B, Mayer J, Weber K, Hoffmann R, Peter JH (1991) Influence on antihypertensive drug therapy on sleep pattern and sleep apnea activity. Cardiology 78:124–130

    Article  PubMed  CAS  Google Scholar 

  • Zarcone VP, Benson KL, Greene KA, Csernansky JG, Faull KF (1994) The effect of chronic alprazolam on sleep and bioamine metabolities in depression. J Clin Psychopharmacol 14:36–40

    Article  PubMed  Google Scholar 

  • Ziegler G, Ludwig L, Klotz U (1983) Effect of midazolam on sleep. Br J Clin Pharmacol 16:81S–86S

    Article  PubMed  Google Scholar 

Download references

Authors
  1. A. Vela-Bueno
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Sleep Research and Treatment Center, Pennsylvania State University College of Medicine M.S. Hershey Medical Center, 500 University Drive, Hershey, PA, 17033, USA

    Anthony Kales M.D. (Professor and Chairman Department of Psychiatry and Director) (Professor and Chairman Department of Psychiatry and Director)

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Vela-Bueno, A. (1995). Anxiolytic Drugs. In: Kales, A. (eds) The Pharmacology of Sleep. Handbook of Experimental Pharmacology, vol 116. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-57836-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-57836-6_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-63372-0

  • Online ISBN: 978-3-642-57836-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation